Home NDC 17312-094-19 Pink Eye Relief PF
Product NDC 17312-094
Requested package NDC 17312-094-19
11-digit product format 173120094
Labeler code 17312
Product ID 17312-094_e5c3f5f5-f9cd-48bd-e053-2a95a90af1d0
Type HUMAN OTC DRUG
Nonproprietary name ACONITUM NAPELLUS - APIS MELLIFERA - SILVER NITRATE - EUPHRASIA STRICTA - SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE -
Dosage form LIQUID
Route OPHTHALMIC
Labeler TRP Company
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2022-08-08
Marketing end 0000-00-00
Substance ACONITUM NAPELLUS; APIS MELLIFERA; EUPHRASIA STRICTA; SILVER NITRATE; SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE
Active strength 6 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
Pharmacologic classes Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 11 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 I Inactivated by FDA 367a005e9d99…383a685ebd0f…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 17312-094 PINK EYE RELIEF PF (ACONITUM NAPELLUS - APIS MELLIFERA - SILVER NITRATE - EUPHRASIA STRICTA - SODIUM ARSENATE, DIBASIC, HEPTAHYDRATE -) LIQUID [TRP COMPANY] 3 Legacy NDC 20230223_e5c3f78b-8799-374b-e053-2995a90a1c42.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 17312-094-19 17312009419 1 BOTTLE, DROPPER in 1 PACKAGE (17312-094-19) > 10 mL in 1 BOTTLE, DROPPER 2022-08-08 0000-00-00 No No Current